1. Text: | Print|

      MOC decries commercial bribery in wake of GSK case

      2013-07-18 10:08 Global Times Web Editor: qindexing
      1

      The Chinese government is firmly opposed to all types of commercial bribery, a spokesperson for the Ministry of Commerce (MOC) said at a press conference Wednesday following a recent case in which four senior executives of British drug manufacturer GlaxoSmithKline (GSK) were suspected of commercial bribery in China.

      No matter whether an enterprise is domestic or foreign, once it has violated Chinese laws, it must be penalized and take full responsibility, said Ministry of Commerce spokesman Shen Danyang, emphasizing that even a famous multinational corporation such as GSK must obey Chinese laws when doing business in China.

      The Ministry of Public Security recently started an investigation of GSK and found evidence that GSK and related companies may have committed serious crimes of commercial bribery and tax-related violations in China. Further investigation is ongoing, according to Shen.

      GSK published an announcement Monday saying that the company was disappointed with the illegal actions of its staff members and related third-party agencies, and that it will not tolerate such actions.

      Some foreign media have commented that the Chinese government's investigation of GSK indicates that China is becoming aggressive in regulating its investment environment.

      Shen said at the press conference that "the Chinese government has always insisted on its opening-up policies, and will never change its policies about proactively attracting foreign capital."

      China's attitude and actions in the GSK case show that China will continue its efforts to improve its investment environment and create a fair competitive environment for investors around the world, said Shen.

      Following the GSK probe in China, two other well-known global drug manufacturers, Novartis and Roche, which also have large market share in the country, both announced they were not contacted by the Chinese government, Reuters reported Wednesday.

      "We have not been contacted by Chinese authorities on this matter," Novartis Chief Executive Joseph Jimenez was quoted as saying in a Reuters report.

      Roche also said it had not been approached by officials in China.

      "We are not aware of any anti-corruption probes in China against Roche. We are committed to ensure the same high standards of compliance for all Roche employees worldwide," a spokesperson was quoted by Reuters as saying.

      Comments (0)
      Most popular in 24h
        Archived Content
      Media partners:

      Copyright ©1999-2018 Chinanews.com. All rights reserved.
      Reproduction in whole or in part without permission is prohibited.

      主站蜘蛛池模板: 免费看片在线观看| 精品韩国亚洲av无码不卡区| 一级成人a做片免费| 日韩一级免费视频| 亚洲偷自拍另类图片二区| 在线观看成人免费视频不卡| 久久亚洲熟女cc98cm| 久久久精品2019免费观看 | 国产精品麻豆免费版| 亚洲国产综合AV在线观看| 手机看片久久国产免费| 老司机免费午夜精品视频| 免费人成在线观看网站视频 | 午夜肉伦伦影院久久精品免费看国产一区二区三区 | 亚洲伊人成无码综合网| 亚洲精品偷拍视频免费观看| 国产午夜亚洲不卡| 免费观看91视频| 亚洲高清中文字幕综合网| 黄色成人免费网站| 精品亚洲视频在线| 在线播放亚洲第一字幕| 久久99精品国产免费观看| 亚洲不卡中文字幕| 国产人成免费视频| 中国一级全黄的免费观看| 亚洲av日韩av激情亚洲| 国产一卡2卡3卡4卡2021免费观看| 亚洲一本到无码av中文字幕 | 两个人看的www免费高清| 亚洲免费视频在线观看| 歪歪漫画在线观看官网免费阅读 | 婷婷亚洲久悠悠色悠在线播放| 18女人毛片水真多免费| 亚洲1区2区3区精华液| 亚洲中文字幕无码久久精品1 | 免费理论片51人人看电影| 国产曰批免费视频播放免费s| 亚洲一卡2卡3卡4卡5卡6卡| 久久亚洲精品无码观看不卡| 亚洲电影免费观看|